The use of mineralocorticoid receptor antagonists for patients with heart failure with a reduced ejection fraction: A time for reassessment

Eur J Heart Fail. 2023 Dec;25(12):2174-2176. doi: 10.1002/ejhf.3091. Epub 2023 Nov 29.

Authors

Bertram Pitt¹, Faiez Zannad²

Affiliations

¹ Division of Cardiology, University of Michigan School of Medicine, Ann Arbor, MI, USA.
² Université de Lorraine, Inserm CIC 1433, and CHRU, Nancy, France.

PMID: 37953723
DOI: 10.1002/ejhf.3091

No abstract available

Publication types

Editorial

MeSH terms

Angiotensin Receptor Antagonists / pharmacology
Heart Failure* / drug therapy
Humans
Mineralocorticoid Receptor Antagonists* / pharmacology
Mineralocorticoid Receptor Antagonists* / therapeutic use
Stroke Volume

Substances

Mineralocorticoid Receptor Antagonists
Angiotensin Receptor Antagonists